The combined net Q3 2024 revenue of approximately $3.1 million for prescription and non-prescription products, including license revenue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback